Literature DB >> 8520779

Localization of platelet-derived growth factor and insulin-like growth factor I in the fibrotic lung.

S Homma1, I Nagaoka, H Abe, K Takahashi, K Seyama, T Nukiwa, S Kira.   

Abstract

To better understand the mechanisms responsible for the increase in numbers of fibroblasts and increased collagen synthesis in fibrotic intestitial lung diseases, platelet-derived growth factor (PDGF)-A and PDGF-B, PDGF receptor-alpha and -beta, insulin-like growth factor I (IGF-I), and IGF-I receptor were evaluated immunohistochemically. Additionally, the messenger ribonucleic acids (mRNAs) for PDGF-A and PDGF-B, PDGF receptor-alpha and -beta, and IGF-I were investigated by in situ hybridization in alveolar macrophages and lung tissues from patients with interstitial lung disease. In specimens of bronchoalveolar lavage fluid (BALF), PDGF-A, PDGF-B, and IGF-I were local in alveolar macrophages in patients with idiopathic pulmonary fibrosis (IPF), patients with sarcoidosis (Sar), and normal individuals. Although there were no differences between IPF and Sar in terms of the staining intensity or number of positive cells, the number of such cells was smaller in the normal controls. In lung tissues with early-stage IPF, PDGF and IGF-I proteins were localized exclusively in alveolar macrophages, mononuclear phagocytes, fibroblasts, alveolar Type II cells, vascular endothelial cells, and vascular smooth-muscle cells. In lung tissues with late-stage IPF and those from normal controls, only alveolar macrophages contained PDGF and IGF-I proteins. Interestingly, the cellular localizations of PDGF receptor-alpha and -beta, and of IGF-I receptor were the same as those of the PDGF and IGF-I proteins in early-stage IPF, whereas these cells were not positive for any of these substances in late-stage IPF or normal controls.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8520779     DOI: 10.1164/ajrccm.152.6.8520779

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  28 in total

Review 1.  Treatment of adult respiratory distress syndrome: plea for rescue therapy of the alveolar epithelium.

Authors:  Y Berthiaume; O Lesur; A Dagenais
Journal:  Thorax       Date:  1999-02       Impact factor: 9.139

Review 2.  Disorders of lung matrix remodeling.

Authors:  Harold A Chapman
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

3.  Alveolar epithelial cells express mesenchymal proteins in patients with idiopathic pulmonary fibrosis.

Authors:  Cecilia Marmai; Rachel E Sutherland; Kevin K Kim; Gregory M Dolganov; Xiaohui Fang; Sophia S Kim; Shuwei Jiang; Jeffery A Golden; Charles W Hoopes; Michael A Matthay; Harold A Chapman; Paul J Wolters
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-04-15       Impact factor: 5.464

4.  Direct measurement of IGF-I and IGFBP-3 in bronchoalveolar lavage fluid from idiopathic pulmonary fibrosis.

Authors:  L Pala; S Giannini; E Rosi; B Cresci; G Scano; S Mohan; R Duranti; C M Rotella
Journal:  J Endocrinol Invest       Date:  2001-12       Impact factor: 4.256

Review 5.  Role of platelet-derived growth factors in physiology and medicine.

Authors:  Johanna Andrae; Radiosa Gallini; Christer Betsholtz
Journal:  Genes Dev       Date:  2008-05-15       Impact factor: 11.361

6.  The expression of PDGF-B chain mRNA in lung tissue from rats repeatedly infected with mycoplasma pneumoniae.

Authors:  J Liu; D Peng; Z Zhu; D Che; M Yang; D Li
Journal:  J Tongji Med Univ       Date:  1998

7.  A novel computational approach for drug repurposing using systems biology.

Authors:  Azam Peyvandipour; Nafiseh Saberian; Adib Shafi; Michele Donato; Sorin Draghici
Journal:  Bioinformatics       Date:  2018-08-15       Impact factor: 6.937

8.  Nickel nanoparticles enhance platelet-derived growth factor-induced chemokine expression by mesothelial cells via prolonged mitogen-activated protein kinase activation.

Authors:  Ellen E Glista-Baker; Alexia J Taylor; Brian C Sayers; Elizabeth A Thompson; James C Bonner
Journal:  Am J Respir Cell Mol Biol       Date:  2012-06-14       Impact factor: 6.914

9.  Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.

Authors:  Hongmei Gu; Amanda J Fisher; Elizabeth A Mickler; Frank Duerson; Oscar W Cummings; Marc Peters-Golden; Homer L Twigg; Trent M Woodruff; David S Wilkes; Ragini Vittal
Journal:  FASEB J       Date:  2016-03-08       Impact factor: 5.191

10.  Insulin-like growth factor-II is increased in systemic sclerosis-associated pulmonary fibrosis and contributes to the fibrotic process via Jun N-terminal kinase- and phosphatidylinositol-3 kinase-dependent pathways.

Authors:  Eileen Hsu; Carol A Feghali-Bostwick
Journal:  Am J Pathol       Date:  2008-05-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.